American Heart Association 2015 Scientific Sessions

American Heart Association 2015 Scientific Sessions | AHA 2015

The AHA Scientific Sessions will cover "the most timely and significant advances in basic, clinical, translational and population health research, spanning the full spectrum of cardiovascular disease from a variety of perspectives, from prevention, through diagnosis and through treatment."

Conference Coverages

Sports Medicine: High Volume Training Improves Arterial Function
Sports Medicine: High Volume Training Improves Arterial Function
Highly trained female athletes showed no sign of a negative effect on their hearts after intense workouts--contradicting studies that found such maximal excercise can be counter-productive, researchers said at the AHA meeting in Orlando, FL.
Angina in Women Linked to Abnormal Heart Blood Flow
Heart disease presents differently in women, and a drug for angina that works for most men did not help most women with their angina, researchers reported today.
Algae-Based Injectable Implant Device Improved Heart Function
Injecting globs of a biopolymer based on brown algae into the heart muscle of patients with advanced heart disease helped halt or reverse disease. The procedure is meant to thicken the ventricle wall. That reduces pumping stress.
Novel Reversal Agent Found Effective
An investigational drug called andexanet alfa that can reverse the anticoagulant effects of FXa inhibitors met all primary and secondary efficacy endpoints, researchers said in a late-breaking clinical trial report at the AHA meeting in Orlando.
Q&A With Christopher Sun From University of Toronto: Automated External Defibrillators Only As Good As Ability to Reach Them VIDEO
Automatic external defibrillators are becoming more common throughout the country and the world helping to save countless lives. However with some devices not available at all times of the day there are questions about how they could be used more effectively
Q&A With Matthew G. Nayor From Brigham & Women's Hospital: Framingham Heart Study Looks At Impact of Carbon Monoxide VIDEO
The Framingham Heart Study has been one of the most in depth studies in the field of cardiology and medicine as a whole. A recent portion of the study looked at the impact of carbon monoxide exhalation and its role in patient health.
Evaluating the Risk/Benefit Profile of Ticagrelor
Analysis of data from the PEGASUS-TIMI 54 trial showed high rates of treatment discontinuation due to adverse events such as bleeding and dyspnea, with the highest rate occurring in the first year of treatment. Patients who stuck with treatment experienced a reduction in cardiovascular death, myocardial infarction, and stroke.
PROACT-4 Trial on Benefits of Troponin Testing for Acute Cardiovascular Disease
Chest pain is one of the most common reasons that patients visit the emergency room, and the use of troponin testing can help cut down the time between first medical contact to final patient disposition.
OK to Give tPA to Stroke Patients on NOACs
Intravenous administration of tissue plasminogen activator (tPA) appears safe in selected patients who were already on novel oral anticoagulants (NOACs) a team reported at the American Heart Association Annual Scientitific Session in Orlando, FL.

Most Popular

@MDMagazine

$vacMongoViewPlus$ $vAR$